IMUX News
Immunic Names Jaa Roberson Chief People Officer
(RTTNews) - On Monday, Immunic, Inc. (IMUX), a biotechnology company developing oral treatments for neurological diseases, appointed Jaa Roberson as Chief People Officer, effective immediately. She will report to CEO Erik Lundgren and join the executive leadership team...
Nasdaq News: Markets
Immunic Names Jaa Roberson Chief People Officer
(RTTNews) - On Monday, Immunic, Inc. (IMUX), a biotechnology company developing oral treatments for neurological diseases, appointed Jaa Roberson as Chief People Officer, effective immediately. She will report to CEO Erik Lundgren and join the executive leadership team...
Nasdaq News: Markets
Immunic Appoints Jaa Roberson as Chief People Officer
Immunic Appoints Jaa Roberson as Chief People Officer Immunic Appoints Jaa Roberson as Chief People OfficerPR NewswireNEW YORK, Oct. 19, 2026 Appointment Supports Immunic's Strategy to Build a Leading Multiple Sclerosis Organization Ahead of Potential Transition to Fully Integrated Commercial...
PR Newswire
Immunic to Present New Clinical, Biomarker and Preclinical Data on Vidofludimus Calcium at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting
Immunic to Present New Clinical, Biomarker and Preclinical Data on Vidofludimus Calcium at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting Immunic to Present New Clinical, Biomarker and Preclinical Data on Vidofludimus Calcium at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS MeetingPR...
PR Newswire
Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026
Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026 Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026 PR Newswire NEW YORK, Sept. 2, 2026 NEW YORK, Sept. 2, 2026 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX),a late-stage biotechnology...
PR Newswire
Immunic Appoints Chitrang Dav as Chief Data and Digital Officer
Immunic Appoints Chitrang Dav as Chief Data and Digital Officer Immunic Appoints Chitrang Dav as Chief Data and Digital Officer PR Newswire NEW YORK, Sept. 1, 2026 New C-Suite Role and Appointment Underscore Commitment to Building a Strong, Commercial-Ready Data Ecosystem, in Preparation for...
PR Newswire
Can Immunic (IMUX) Climb 163.03% to Reach the Level Wall Street Analysts Expect?
The mean of analysts' price targets for Immunic (IMUX) points to a 163% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks
Immunic advances MS drug toward key Phase 3 data, expects results by year-end
Immunic advances MS drug toward key Phase 3 data, expects results by year-end...
Yahoo! Finance: News
Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update PR Newswire NEW YORK, Aug. 11, 2026 Leadership Team Expanded with Key Executive Appointments, Including Chief Executive...
PR Newswire
Immunic Appoints Elena Ridloff to Board of Directors
Immunic Appoints Elena Ridloff to Board of Directors Immunic Appoints Elena Ridloff to Board of Directors PR Newswire NEW YORK, Aug. 10, 2026 Appointment Strengthens Board with Financial, Capital Markets and Commercial Leadership Expertise as the Company Approaches Pivotal Phase 3 ENSURE Readout in...
PR Newswire
Immunic to Participate in Investor Conferences in July
Immunic to Participate in Investor Conferences in July Immunic to Participate in Investor Conferences in July PR Newswire NEW YORK, July 9, 2026 NEW YORK, July 9, 2026 /PRNewswire/ --Immunic, Inc. (Nasdaq: IMUX),a late-stage biotechnology company pioneering the development of novel oral therapies...
PR Newswire